correlational
Analysis v1
33
0
People with type 2 diabetes have less MOTS-c in their blood than people without diabetes.
Scientific Claim
Circulating MOTS-c levels are lower in individuals with type 2 diabetes compared to healthy controls.
Original Statement
“In humans, circulating MOTS-c levels are lower in type 2 diabetes patients compared with healthy controls.”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The claim uses 'are lower' which describes an association observed in the data without implying causation. The study design (observational human cohort) supports this type of claim.
Evidence from Studies
Supporting (1)
33
33
Mitochondrial-encoded peptide MOTS-c prevents pancreatic islet cell senescence to delay diabetes
Randomized Controlled Trial
Human
2025 AugContradicting (0)
0
No contradicting evidence found